Barbara Jean Robinson, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3880 Falmouth Road, Cotuit, MA 02635 Phone: 508-778-4777 |
News Archive
Some current therapies being investigated for Alzheimer's disease may cause further neural degeneration and cell death, according to a breakthrough discovery by UC San Diego researchers. By combining three dimensional computer simulations with high resolution atomic force microscopy membrane protein and cell imaging, electrical recording and various cellular assays, UCSD nano-biophysicist Ratnesh Lal and his colleagues investigated the structure and function of truncated peptides, known as nonamyloidgenic peptides, formed by some Alzheimer's drug candidates.
Researchers in the U.S. have come up with a "man-made" scorpion venom which they say targets deadly brain tumours called gliomas without affecting neighboring tissue or body organs.
Developmental biologists at the University of Pittsburgh have been chosen to participate in a $100 million federal "Bench to Bassinet" network that is dedicated to learning about the formation of the cardiovascular system and applying that knowledge to create new diagnostic and intervention strategies for congenital heart disease.
In the two decades since the start of "Back to Sleep" campaign, doctors and surgeons have seen a surge in the number of infants with position-related head deformities called deformational plagiocephaly.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
› Verified 4 days ago